Starpharma Holdings Limited (ASX:SPL)
Australia flag Australia · Delayed Price · Currency is AUD
0.7950
-0.0750 (-8.62%)
Oct 1, 2026, 4:10 PM AEST

Starpharma Holdings Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
4152953739127302
Market Cap Growth
350.89%700.60%-5.98%-69.24%-57.90%-50.21%
Enterprise Value
405277191091255
Last Close Price
0.870.680.090.090.300.72

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-34.9434.9434.9434.9434.94
PS Ratio
32.7523.266.294.0129.3058.55
PB Ratio
30.1121.391.941.393.666.25
P/TBV Ratio
30.1121.391.941.393.666.25

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
31.9321.883.251.0420.9749.34

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.050.050.130.130.240.17
Net Debt / Equity Ratio
-0.75-0.75-0.68-0.70-0.77-0.86
Net Debt / EBITDA Ratio
1.441.441.342.531.772.64
Net Debt / FCF Ratio
2.952.951.912.811.802.98
Asset Turnover
0.570.570.190.220.070.07
Inventory Turnover
6.666.664.434.134.426.36
Quick Ratio
2.982.983.764.463.005.65
Current Ratio
3.403.404.324.943.265.93
Return on Equity (ROE)
-45.55%-45.55%-42.41%-25.95%-37.59%-29.19%
Return on Assets (ROA)
-21.00%-21.00%-20.06%-11.48%-16.53%-14.48%
Return on Capital Employed (ROCE)
-53.90%-53.90%-49.50%-27.10%-41.60%-28.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-1.80%-2.53%-27.14%-20.86%-12.29%-5.34%
FCF Yield
-0.84%-1.19%-18.48%-18.05%-11.73%-4.63%
Buyback Yield / Dilution
-0.61%-0.61%-1.40%-0.59%-0.53%-2.53%